Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effects of Antimuscarinic Drugs on Ejaculation Duration and Refractory Period in Male Patients Treated for Overactive Bladder: An Observational Study

NCT07736560 is registered in ClinicalTrials.gov with Başakşehir Çam & Sakura City Hospital as lead sponsor.

NCT NCT07736560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07736560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effects of Antimuscarinic Drugs on Ejaculation Duration and Refractory Period in Male Patients Treated for Overactive Bladder: An Observational Study
Lead sponsor
Başakşehir Çam & Sakura City Hospital
Phase
Observational
Overall status
Completed
Start date
January 15, 2026
Completion date
June 30, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ejaculation abnormal, overactive bladder (oab), premature (early) ejaculation